Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 840.00
-25.00 (-2.89%)
Apr 24, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 54.36 billion as of April 24, 2026. Its market cap has increased by 548.61% in one year.
Market Cap
54.36B
Enterprise Value
54.21B
Revenue
31.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
840.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 54.36B, an increase of 878.43%. That is a compound annual growth rate of 191.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 54.36B | 170.98% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 170.42B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 24.63B |
| Lumosa Therapeutics | 21.52B |
| Sunmax Biotechnology | 21.46B |
| AP Biosciences | 17.11B |
| Medigen Vaccine Biologics | 15.39B |
| Polaris Group | 15.22B |